Síguenos en Twitter     Síguenos en Facebook     Síguenos en Google+     Síguenos en YouTube     Siguenos en Linkedin     Correo Grupsagessa     Gmail     Yahoo Mail     Dropbox     Instagram     Pinterest     Slack     Google Drive     Reddit     StumbleUpon     Print

SOBRE EL AUTOR **

Mi foto
FACP. Colegio de médicos de Tarragona Nº 4305520 / fgcapriles@gmail.com

WORLD EMERGENCY MEDICINE SOCIETIES

iSepsis – Understanding Lactate

Buscar en contenido

Contenido:

lunes, 16 de enero de 2017

Mg+ for COPD/Asthma

Mizzou EM - January 16, 2017 - By mizzouem 
"In what populations does intravenous or nebulized magnesium sulfate provide benefit?
BOTTOM LINE
The research on the benefit of magnesium sulfate- either intravenous or nebulized- for the treatment of acute exacerbations of asthma and COPD are scattered and of varying quality, sample size, and relevance to the US population. However, there does appear to be some support of use of intravenous magnesium in the treatment of asthma and potentially for COPD exacerbations– although the volume data on the latter is even more lacking. There did not, however, appear to be any significant adverse effects of magnesium infusion or inhaled therapy in the studies evaluated, suggesting that it may be worth consideration in patients who do not demonstrate significant improvement with initiation of standard therapy."